apalutamide 60 MG Oral Tablet [Erleada]
- RxCUI
- 1999587
- RxNorm name
- apalutamide 60 MG Oral Tablet [Erleada]
- Display name
- apalutamide 60 MG Oral Tablet [Erleada]
- Full name
- apalutamide 60 MG Oral Tablet [Erleada]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ERLEADA | APALUTAMIDE | Janssen Products, LP | d1cda4f7-cb33-46ea-b9ac-431f6452b1a5 | 2026-07-02 | Warnings, Adverse reactions | 1999587 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d1cda4f7-cb33-46ea-b9ac-431f6452b1a5 | apalutamide 60 MG Oral Tablet [Erleada] | SBD | 28 | These highlights do not include all the information needed to use ERLEADA safely and effectively. See full prescribing information for ERLEADA. ERLEADA ® (apalutamide) tablets, for oral use Initial U.S. Approval – 2018 | 20260310 |
| d1cda4f7-cb33-46ea-b9ac-431f6452b1a5 | Erleada 60 MG Oral Tablet | PSN | 28 | These highlights do not include all the information needed to use ERLEADA safely and effectively. See full prescribing information for ERLEADA. ERLEADA ® (apalutamide) tablets, for oral use Initial U.S. Approval – 2018 | 20260310 |
| d1cda4f7-cb33-46ea-b9ac-431f6452b1a5 | Erleada 60 MG Oral Tablet | SY | 28 | These highlights do not include all the information needed to use ERLEADA safely and effectively. See full prescribing information for ERLEADA. ERLEADA ® (apalutamide) tablets, for oral use Initial U.S. Approval – 2018 | 20260310 |